Putnam Investments’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $880M | Sell |
1,510,259
-118,702
| -7% | -$69.3M | 1.16% | 20 |
|
|
2023
Q3 | $875M | Sell |
1,628,961
-183,036
| -10% | -$94.3M | 1.33% | 12 |
|
|
2023
Q2 | $850M | Buy |
1,811,997
+2,598
| +0.1% | +$1.09M | 1.25% | 14 |
|
|
2023
Q1 | $621M | Buy |
1,809,399
+19,865
| +1% | +$6.7M | 1% | 21 |
|
|
2022
Q4 | $655M | Buy |
1,789,534
+36,498
| +2% | +$12.9M | 1.14% | 19 |
|
|
2022
Q3 | $567M | Buy |
1,753,036
+451,536
| +35% | +$143M | 1.08% | 20 |
|
|
2022
Q2 | $422M | Buy |
1,301,500
+34,089
| +3% | +$10.2M | 0.76% | 38 |
|
|
2022
Q1 | $363M | Sell |
1,267,411
-362,532
| -22% | -$93.3M | 0.55% | 59 |
|
|
2021
Q4 | $450M | Sell |
1,629,943
-403,443
| -20% | -$102M | 0.64% | 47 |
|
|
2021
Q3 | $470M | Sell |
2,033,386
-2,115,124
| -51% | -$522M | 0.73% | 34 |
|
|
2021
Q2 | $952M | Sell |
4,148,510
-280,133
| -6% | -$56.3M | 1.48% | 6 |
|
|
2021
Q1 | $827M | Sell |
4,428,643
-140,367
| -3% | -$27.5M | 1.38% | 10 |
|
|
2020
Q4 | $771M | Buy |
4,569,010
+426,791
| +10% | +$63.7M | 1.37% | 10 |
|
|
2020
Q3 | $613M | Buy |
4,142,219
+757,407
| +22% | +$117M | 1.21% | 15 |
|
|
2020
Q2 | $556M | Buy |
3,384,812
+1,281,767
| +61% | +$197M | 1.18% | 18 |
|
|
2020
Q1 | $292M | Sell |
2,103,045
-40,830
| -2% | -$5.61M | 0.76% | 31 |
|
|
2019
Q4 | $282M | Sell |
2,143,875
-225,126
| -10% | -$26.1M | 0.58% | 44 |
|
|
2019
Q3 | $265M | Sell |
2,369,001
-218,331
| -8% | -$24.3M | 0.59% | 45 |
|
|
2019
Q2 | $287M | Buy |
2,587,332
+184,437
| +8% | +$21.7M | 0.64% | 38 |
|
|
2019
Q1 | $312M | Sell |
2,402,895
-196,066
| -8% | -$23.8M | 0.73% | 28 |
|
|
2018
Q4 | $301M | Buy |
2,598,961
+477,348
| +22% | +$53.3M | 0.79% | 29 |
|
|
2018
Q3 | $228M | Buy |
2,121,613
+47,576
| +2% | +$4.76M | 0.49% | 55 |
|
|
2018
Q2 | $177M | Sell |
2,074,037
-3,455
| -0.2% | -$284K | 0.4% | 67 |
|
|
2018
Q1 | $161M | Buy |
2,077,492
+45,215
| +2% | +$3.64M | 0.37% | 81 |
|
|
2017
Q4 | $172M | Sell |
2,032,277
-670,443
| -25% | -$57M | 0.38% | 75 |
|
|
2017
Q3 | $231M | Sell |
2,702,720
-34,366
| -1% | -$2.82M | 0.53% | 45 |
|
|
2017
Q2 | $225M | Sell |
2,737,086
-1,603,636
| -37% | -$131M | 0.53% | 43 |
|
|
2017
Q1 | $365M | Buy |
4,340,722
+231,363
| +6% | +$18.5M | 0.86% | 22 |
|
|
2016
Q4 | $302M | Sell |
4,109,359
-797,575
| -16% | -$59.4M | 0.73% | 29 |
|
|
2016
Q3 | $394M | Buy |
4,906,934
+133,534
| +3% | +$10.7M | 0.95% | 21 |
|
|
2016
Q2 | $376M | Buy |
4,773,400
+402,175
| +9% | +$30.3M | 0.92% | 19 |
|
|
2016
Q1 | $315M | Sell |
4,371,225
-535,371
| -11% | -$40.5M | 0.75% | 26 |
|
|
2015
Q4 | $413M | Buy |
4,906,596
+158,383
| +3% | +$13.1M | 0.93% | 21 |
|
|
2015
Q3 | $397M | Buy |
4,748,213
+386,700
| +9% | +$32.6M | 0.89% | 20 |
|
|
2015
Q2 | $364M | Sell |
4,361,513
-109,798
| -2% | -$8.37M | 0.73% | 28 |
|
|
2015
Q1 | $325M | Sell |
4,471,311
-119,538
| -3% | -$8.51M | 0.65% | 28 |
|
|
2014
Q4 | $317M | Sell |
4,590,849
-216,848
| -5% | -$14.6M | 0.65% | 27 |
|
|
2014
Q3 | $312M | Sell |
4,807,697
-11,092
| -0.2% | -$702K | 0.66% | 29 |
|
|
2014
Q2 | $300M | Sell |
4,818,789
-725,785
| -13% | -$43.3M | 0.64% | 28 |
|
|
2014
Q1 | $326M | Sell |
5,544,574
-433,405
| -7% | -$24.2M | 0.74% | 24 |
|
|
2013
Q4 | $305M | Sell |
5,977,979
-582,111
| -9% | -$29.1M | 0.73% | 24 |
|
|
2013
Q3 | $330M | Buy |
6,560,090
+83,344
| +1% | +$4.36M | 0.88% | 14 |
|
|
2013
Q2 | $318M | Buy |
+6,476,746
| New | +$352M | 0.93% | 14 |
|
Other funds holding LLY
Putnam Investments's LLY Position: Q4 2023 in Review
Putnam Investments reduced its Eli Lilly (LLY) stake by 7.3% in Q4 2023, selling an estimated $69.3M and leaving 1,510,259 shares worth $880M. The position accounts for 1.16% of the portfolio, ranked #20.
Putnam Investments first reported a position in LLY in Q2 2013 and has held it in 43 quarters since. The position peaked at $952M in Q2 2021. 3,272 funds tracked by Wall St. Rank hold LLY as of Q4 2023.
- Putnam Investments held 1,510,259 shares of Eli Lilly worth $880M as of Q4 2023.
- Putnam Investments sold 118,702 Eli Lilly shares in Q4 2023, an estimated $69.3M.
- Eli Lilly made up 1.16% of Putnam Investments's portfolio in Q4 2023, its #20 holding.
- Putnam Investments first reported a position in Eli Lilly in Q2 2013 and has held it in 43 quarters since.
- Putnam Investments's Eli Lilly position peaked at $952M in Q2 2021.
- 3,272 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.